Sanduo Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sanduo Zheng has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Sijia Chen
Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University
5 shared publicationsYingying Nie
College of Life Sciences, Beijing Normal University
4 shared publicationsJiahao Ma
Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China; National Institute of Biological Sciences, Beijing 102206, China
3 shared publications- Niu Huang
Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 102206, China
3 shared publications Wentong Jiang
National Institute of Biological Sciences
3 shared publications- Xiao Teng
Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 10 September 2025
- Published by Springer Nature in Nature Synthesis
- Vol. 4 (12) , 1621-1629
Molecular-dynamics-simulation-guided directed evolution of flavoenzymes for atroposelective desaturation
- 10 September 2025
- Published by Springer Nature in Nature Synthesis
- Vol. 4 (12) , 1621-1629
Open AccessMolecular-dynamics-simulation-guided directed evolution of flavoenzymes for atroposelective desaturation
- 10 September 2025
- Published by Springer Nature
- p. 143-157
KCTD Family: Emerging Regulators of GPCR Biased Signaling
G protein-coupled receptors (GPCRs) engage multiple transducers to regulate distinct physiological processes. These transducers include various G proteins subtypes, GPCR kinases (GRKs), and β-arrestins. In addition to promoting receptor desensitization, β-arrestins serve as scaffolds for signaling via non-G protein pathways. Biased signaling enables GPCRs to selectively engage specific transducers, typically through different conformational states of GPCRs. While significant focus has been placed on developing biased ligands that preferentially activate specific G proteins or β-arrestins, the strategy focused on modulating particular G protein subunits (Gα versus βγ) remains underexplored. Recently, members of the KCTD (potassium channel tetramerization domain-containing) family have emerged as critical regulators of GPCR signaling, particularly through their roles in mediating Gβγ degradation or uncoupling Gβγ from downstream effectors. This ability positions the KCTD family as potential targets for selectively modulating Gβγ signaling with minimal impact on Gα-mediated pathways. In this chapter, we introduce the KCTD family, summarize current knowledge of their role in GPCR signaling regulation, and highlight unsolved questions in existing models, along with directions for future research.
- 10 September 2025
- Published by Springer Nature
- p. 143-157
KCTD Family: Emerging Regulators of GPCR Biased Signaling
G protein-coupled receptors (GPCRs) engage multiple transducers to regulate distinct physiological processes. These transducers include various G proteins subtypes, GPCR kinases (GRKs), and β-arrestins. In addition to promoting receptor desensitization, β-arrestins serve as scaffolds for signaling via non-G protein pathways. Biased signaling enables GPCRs to selectively engage specific transducers, typically through different conformational states of GPCRs. While significant focus has been placed on developing biased ligands that preferentially activate specific G proteins or β-arrestins, the strategy focused on modulating particular G protein subunits (Gα versus βγ) remains underexplored. Recently, members of the KCTD (potassium channel tetramerization domain-containing) family have emerged as critical regulators of GPCR signaling, particularly through their roles in mediating Gβγ degradation or uncoupling Gβγ from downstream effectors. This ability positions the KCTD family as potential targets for selectively modulating Gβγ signaling with minimal impact on Gα-mediated pathways. In this chapter, we introduce the KCTD family, summarize current knowledge of their role in GPCR signaling regulation, and highlight unsolved questions in existing models, along with directions for future research.
- 22 August 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 435-445
SARM1 activation promotes axonal degeneration via a two-step phase transition
SARM1 is a key executioner of axonal degeneration, acting through NAD⁺ depletion by NADase activity of its TIR domain. Although normally autoinhibited, SARM1 becomes activated in response to axonal damage; however, the underlying mechanism remains unclear. Here, using a class of pyridine-containing compounds that trigger SARM1-dependent axon degeneration, we uncover a two-step activation process. First, NMN primes the base exchange activity of SARM1, generating covalent adducts between ADP-ribose (an NAD⁺ hydrolysis product) and the compounds. These ADP-ribose conjugates then serve as molecular glues to promote the assembly of superhelical SARM1 filaments, in which TIR domains adopt an active configuration. After reaching solubility limits, these filaments condense into stable, phase-separated assemblies with full enzymatic activity. Unexpectedly, several clinical-stage SARM1 inhibitors targeting its TIR domain also form such adducts, paradoxically promoting its activation. These findings reveal a molecular mechanism that spatially restricts SARM1 activation to damaged axons and offer new guidance for therapeutic strategies targeting SARM1.
- 22 August 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 435-445
SARM1 activation promotes axonal degeneration via a two-step phase transition
SARM1 is a key executioner of axonal degeneration, acting through NAD⁺ depletion by NADase activity of its TIR domain. Although normally autoinhibited, SARM1 becomes activated in response to axonal damage; however, the underlying mechanism remains unclear. Here, using a class of pyridine-containing compounds that trigger SARM1-dependent axon degeneration, we uncover a two-step activation process. First, NMN primes the base exchange activity of SARM1, generating covalent adducts between ADP-ribose (an NAD⁺ hydrolysis product) and the compounds. These ADP-ribose conjugates then serve as molecular glues to promote the assembly of superhelical SARM1 filaments, in which TIR domains adopt an active configuration. After reaching solubility limits, these filaments condense into stable, phase-separated assemblies with full enzymatic activity. Unexpectedly, several clinical-stage SARM1 inhibitors targeting its TIR domain also form such adducts, paradoxically promoting its activation. These findings reveal a molecular mechanism that spatially restricts SARM1 activation to damaged axons and offer new guidance for therapeutic strategies targeting SARM1.
- Open Access
- 30 July 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (31)
ELAPOR1 is a copper-dependent tethering factor driving proacrosomal vesicle fusion during acrosome biogenesis
The acrosome is a crucial organelle essential for sperm function and male fertility. During acrosome biogenesis, numerous proacrosomal vesicles (PAVs) are transported to the concave region of the nuclear membrane and fuse to form the acrosome. However, the mechanisms governing the fusion of PAVs to form the acrosome remain poorly understood. Here, we identify endosome-lysosome associated apoptosis and autophagy regulator 1 (ELAPOR1), a conserved protein, as a key factor in PAVs fusion during acrosome biogenesis. Male mice lacking Elapor1 ( Elapor1 −/− ) are infertile, exhibiting defective acrosome biogenesis and a globozoospermia-like phenotype. Using cryo-electron microscopy revealed that ELAPOR1 forms a square planar homodimer in cis, which assembles into a trans-tetramer via head-to-head homophilic interactions dependent on copper chelation. Notably, ELAPOR1 exhibits dual membrane orientation, with a predicted N in − C out topology and a noncanonical N out − C in topology in vesicles. The noncanonical N out − C in topology enables ELAPOR1 to function as a tethering factor bridging vesicles through head-to-head homophilic interactions. A mutant ELAPOR1 (ELAPOR1 4HA ) incapable of copper chelation forms cis homodimers but fails to mediate homophilic interactions in vitro, leading to defective PAVs fusion in mice, phenocopying the Elapor1 -deficient mice. Additionally, ELAPOR1 was shown to interact with soluble N-ethylmaleimide sensitive factor attachment protein receptors protein STX12. Conditional knockout of Stx12 in germ cells resulted in similar defects in acrosome biogenesis. Collectively, our findings suggest that ELAPOR1 functions as a tethering factor that regulates PAV fusion through a copper-dependent mechanism.
- 30 July 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (31)
Open AccessELAPOR1 is a copper-dependent tethering factor driving proacrosomal vesicle fusion during acrosome biogenesis
The acrosome is a crucial organelle essential for sperm function and male fertility. During acrosome biogenesis, numerous proacrosomal vesicles (PAVs) are transported to the concave region of the nuclear membrane and fuse to form the acrosome. However, the mechanisms governing the fusion of PAVs to form the acrosome remain poorly understood. Here, we identify endosome-lysosome associated apoptosis and autophagy regulator 1 (ELAPOR1), a conserved protein, as a key factor in PAVs fusion during acrosome biogenesis. Male mice lacking Elapor1 ( Elapor1 −/− ) are infertile, exhibiting defective acrosome biogenesis and a globozoospermia-like phenotype. Using cryo-electron microscopy revealed that ELAPOR1 forms a square planar homodimer in cis, which assembles into a trans-tetramer via head-to-head homophilic interactions dependent on copper chelation. Notably, ELAPOR1 exhibits dual membrane orientation, with a predicted N in − C out topology and a noncanonical N out − C in topology in vesicles. The noncanonical N out − C in topology enables ELAPOR1 to function as a tethering factor bridging vesicles through head-to-head homophilic interactions. A mutant ELAPOR1 (ELAPOR1 4HA ) incapable of copper chelation forms cis homodimers but fails to mediate homophilic interactions in vitro, leading to defective PAVs fusion in mice, phenocopying the Elapor1 -deficient mice. Additionally, ELAPOR1 was shown to interact with soluble N-ethylmaleimide sensitive factor attachment protein receptors protein STX12. Conditional knockout of Stx12 in germ cells resulted in similar defects in acrosome biogenesis. Collectively, our findings suggest that ELAPOR1 functions as a tethering factor that regulates PAV fusion through a copper-dependent mechanism.
- Open Access
- 21 July 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Allosteric modulation of dimeric GPR3 by ligands in the dimerization interface
Class C G-protein coupled receptors (GPCRs) are widely recognized to function as a dimer, whereas the existence, molecular mechanisms and functional importance of dimerization in class A GPCRs remain poorly explored. GPR3, GPR6 and GPR12 are closely related to cannabinoid receptors, and are associated with neurogenerative diseases such as Parkinson’s and Alzheimer’s diseases. Here, we determined cryo-EM structures of GPR3-Gs complex in the active state and GPR3 alone in the inactive state. We observe that GPR3 forms symmetric dimers in both states, with the dimerization interface primarily involving TM5 and TM6. Upon activation, GPR3 undergoes an outward movement of TM6 and an inward movement of TM7, alongside stabilization of helix 8, which is disordered in the inactive state. Functionally, GPR3 dimerization attenuates Gs signaling. Furthermore, we identify AF64394 as a negative allosteric modulator that targets the GPR3 dimerization interface and allosterically shifts the α-helical structure of ICL2 into a random coil structure, thereby impairing Gs coupling. Our findings provide structural and mechanistic insights into class A GPCR dimerization, offering potential therapeutic strategies targeting the dimerization interface of these receptors.
- 21 July 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Open AccessAllosteric modulation of dimeric GPR3 by ligands in the dimerization interface
Class C G-protein coupled receptors (GPCRs) are widely recognized to function as a dimer, whereas the existence, molecular mechanisms and functional importance of dimerization in class A GPCRs remain poorly explored. GPR3, GPR6 and GPR12 are closely related to cannabinoid receptors, and are associated with neurogenerative diseases such as Parkinson’s and Alzheimer’s diseases. Here, we determined cryo-EM structures of GPR3-Gs complex in the active state and GPR3 alone in the inactive state. We observe that GPR3 forms symmetric dimers in both states, with the dimerization interface primarily involving TM5 and TM6. Upon activation, GPR3 undergoes an outward movement of TM6 and an inward movement of TM7, alongside stabilization of helix 8, which is disordered in the inactive state. Functionally, GPR3 dimerization attenuates Gs signaling. Furthermore, we identify AF64394 as a negative allosteric modulator that targets the GPR3 dimerization interface and allosterically shifts the α-helical structure of ICL2 into a random coil structure, thereby impairing Gs coupling. Our findings provide structural and mechanistic insights into class A GPCR dimerization, offering potential therapeutic strategies targeting the dimerization interface of these receptors.
- Open Access
Allosteric modulation of dimeric GPR3 by ligands in the dimerization interface
Class C G-protein coupled receptors (GPCRs) are widely recognized to function as a dimer, whereas the existence, molecular mechanisms and functional importance of dimerization in class A GPCRs remain poorly explored. GPR3, GPR6 and GPR12 are closely related to cannabinoid receptors, and are associated with neurogenerative diseases such as Parkinson’s and Alzheimer’s diseases. Here, we determined cryo-EM structures of GPR3-G s complex in the active state and GPR3 alone in the inactive state. We observe that GPR3 forms symmetric dimers in both states, with the dimerization interface primarily involving TM5 and TM6. Upon activation, GPR3 undergoes an outward movement of TM6 and an inward movement of TM7, alongside stabilization of helix 8, which is disordered in the inactive state. Functionally, GPR3 dimerization attenuates G s signaling. Furthermore, we identify AF64394 as a negative allosteric modulator that targets the GPR3 dimerization interface and allosterically shifts the α-helical structure of ICL2 into a random coil structure, thereby impairing G s coupling. Our findings provide structural and mechanistic insights into class A GPCR dimerization, offering potential therapeutic strategies targeting the dimerization interface of these receptors.
Open AccessAllosteric modulation of dimeric GPR3 by ligands in the dimerization interface
Class C G-protein coupled receptors (GPCRs) are widely recognized to function as a dimer, whereas the existence, molecular mechanisms and functional importance of dimerization in class A GPCRs remain poorly explored. GPR3, GPR6 and GPR12 are closely related to cannabinoid receptors, and are associated with neurogenerative diseases such as Parkinson’s and Alzheimer’s diseases. Here, we determined cryo-EM structures of GPR3-G s complex in the active state and GPR3 alone in the inactive state. We observe that GPR3 forms symmetric dimers in both states, with the dimerization interface primarily involving TM5 and TM6. Upon activation, GPR3 undergoes an outward movement of TM6 and an inward movement of TM7, alongside stabilization of helix 8, which is disordered in the inactive state. Functionally, GPR3 dimerization attenuates G s signaling. Furthermore, we identify AF64394 as a negative allosteric modulator that targets the GPR3 dimerization interface and allosterically shifts the α-helical structure of ICL2 into a random coil structure, thereby impairing G s coupling. Our findings provide structural and mechanistic insights into class A GPCR dimerization, offering potential therapeutic strategies targeting the dimerization interface of these receptors.
- Open Access
- 18 February 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (8)
Stepwise activation of SARM1 for cell death and axon degeneration revealed by a biosynthetic NMN mimic
Axon degeneration, driven by the NAD + hydrolyzing enzyme SARM1, is an early pathological hallmark of numerous neurodegenerative diseases. SARM1 exists in an inactive form and is activated following nerve injury. However, the precise molecular mechanism underlying SARM1 activation remains to be fully elucidated. In this study, we report the identification of a potent proactivator of SARM1, G10, which is converted into a direct activator (M1) by the enzyme nicotinamide phosphoribosyltransferase. Cryoelectron microscopy structures of SARM1 bound to M1, as well as to M1 and a nonhydrolyzable NAD + analog (1AD), captured two intermediate activation states and the fully active state, revealing a stepwise mechanism of SARM1 activation. Further, introducing a disulfide bond to prevent conformational transitions between the two intermediate states mediated by M1 stabilized SARM1 in its inactive form and blocked M1-induced cell death. Together, these findings propose a sequential, stepwise activation model for SARM1 and offer a framework for developing potential SARM1 inhibitors for the treatment of neurodegenerative diseases.
- 18 February 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (8)
Open AccessStepwise activation of SARM1 for cell death and axon degeneration revealed by a biosynthetic NMN mimic
Axon degeneration, driven by the NAD + hydrolyzing enzyme SARM1, is an early pathological hallmark of numerous neurodegenerative diseases. SARM1 exists in an inactive form and is activated following nerve injury. However, the precise molecular mechanism underlying SARM1 activation remains to be fully elucidated. In this study, we report the identification of a potent proactivator of SARM1, G10, which is converted into a direct activator (M1) by the enzyme nicotinamide phosphoribosyltransferase. Cryoelectron microscopy structures of SARM1 bound to M1, as well as to M1 and a nonhydrolyzable NAD + analog (1AD), captured two intermediate activation states and the fully active state, revealing a stepwise mechanism of SARM1 activation. Further, introducing a disulfide bond to prevent conformational transitions between the two intermediate states mediated by M1 stabilized SARM1 in its inactive form and blocked M1-induced cell death. Together, these findings propose a sequential, stepwise activation model for SARM1 and offer a framework for developing potential SARM1 inhibitors for the treatment of neurodegenerative diseases.
- Top Cited Papers
- 6 August 2024
- Published by Elsevier in Cell Metabolism
- Vol. 36 (9) , 2118-2129.e6
Zinc transporter 1 functions in copper uptake and cuproptosis
- 6 August 2024
- Published by Elsevier in Cell Metabolism
- Vol. 36 (9) , 2118-2129.e6
Top Cited PapersZinc transporter 1 functions in copper uptake and cuproptosis
- Open Access
- 22 September 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling
Many orphan G protein-coupled receptors (GPCRs) remain understudied because their endogenous ligands are unknown. Here, we show that a group of class A/rhodopsin-like orphan GPCRs including GPR61, GPR161 and GPR174 increase the cAMP level similarly to fully activated D1 dopamine receptor (D1R). We report cryo-electron microscopy structures of the GPR61‒Gs, GPR161‒Gs and GPR174‒Gs complexes without any exogenous ligands. The GPR174 structure reveals that endogenous lysophosphatidylserine (lysoPS) is copurified. While GPR174 fails to respond to exogenous lysoPS, likely owing to its maximal activation by the endogenous ligand, GPR174 mutants with lower ligand binding affinities can be specifically activated by lysoPS but not other lipids, in a dose-dependent manner. Moreover, GPR174 adopts a non-canonical Gs coupling mode. The structures of GPR161 and GPR61 reveal that the second extracellular loop (ECL2) penetrates into the orthosteric pocket, possibly contributing to constitutive activity. Our work definitively confirms lysoPS as an endogenous GPR174 ligand and suggests that high constitutive activity of some orphan GPCRs could be accounted for by their having naturally abundant ligands.
- 22 September 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Open AccessSpecific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling
Many orphan G protein-coupled receptors (GPCRs) remain understudied because their endogenous ligands are unknown. Here, we show that a group of class A/rhodopsin-like orphan GPCRs including GPR61, GPR161 and GPR174 increase the cAMP level similarly to fully activated D1 dopamine receptor (D1R). We report cryo-electron microscopy structures of the GPR61‒Gs, GPR161‒Gs and GPR174‒Gs complexes without any exogenous ligands. The GPR174 structure reveals that endogenous lysophosphatidylserine (lysoPS) is copurified. While GPR174 fails to respond to exogenous lysoPS, likely owing to its maximal activation by the endogenous ligand, GPR174 mutants with lower ligand binding affinities can be specifically activated by lysoPS but not other lipids, in a dose-dependent manner. Moreover, GPR174 adopts a non-canonical Gs coupling mode. The structures of GPR161 and GPR61 reveal that the second extracellular loop (ECL2) penetrates into the orthosteric pocket, possibly contributing to constitutive activity. Our work definitively confirms lysoPS as an endogenous GPR174 ligand and suggests that high constitutive activity of some orphan GPCRs could be accounted for by their having naturally abundant ligands.
- Open Access
- 14 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (28) , eadg8369
Structural basis for the ubiquitination of G protein βγ subunits by KCTD5/Cullin3 E3 ligase
G protein–coupled receptor (GPCR) signaling is precisely controlled to avoid overstimulation that results in detrimental consequences. Gβγ signaling is negatively regulated by a Cullin3 (Cul3)–dependent E3 ligase, KCTD5, which triggers ubiquitination and degradation of free Gβγ. Here, we report the cryo–electron microscopy structures of the KCTD5-Gβγ fusion complex and the KCTD7-Cul3 complex. KCTD5 in pentameric form engages symmetrically with five copies of Gβγ through its C-terminal domain. The unique pentameric assembly of the KCTD5/Cul3 E3 ligase places the ubiquitin-conjugating enzyme (E2) and the modification sites of Gβγ in close proximity and allows simultaneous transfer of ubiquitin from E2 to five Gβγ subunits. Moreover, we show that ubiquitination of Gβγ by KCTD5 is important for fine-tuning cyclic adenosine 3´,5´-monophosphate signaling of GPCRs. Our studies provide unprecedented insights into mechanisms of substrate recognition by unusual pentameric E3 ligases and highlight the KCTD family as emerging regulators of GPCR signaling.
- 14 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (28) , eadg8369
Open AccessStructural basis for the ubiquitination of G protein βγ subunits by KCTD5/Cullin3 E3 ligase
G protein–coupled receptor (GPCR) signaling is precisely controlled to avoid overstimulation that results in detrimental consequences. Gβγ signaling is negatively regulated by a Cullin3 (Cul3)–dependent E3 ligase, KCTD5, which triggers ubiquitination and degradation of free Gβγ. Here, we report the cryo–electron microscopy structures of the KCTD5-Gβγ fusion complex and the KCTD7-Cul3 complex. KCTD5 in pentameric form engages symmetrically with five copies of Gβγ through its C-terminal domain. The unique pentameric assembly of the KCTD5/Cul3 E3 ligase places the ubiquitin-conjugating enzyme (E2) and the modification sites of Gβγ in close proximity and allows simultaneous transfer of ubiquitin from E2 to five Gβγ subunits. Moreover, we show that ubiquitination of Gβγ by KCTD5 is important for fine-tuning cyclic adenosine 3´,5´-monophosphate signaling of GPCRs. Our studies provide unprecedented insights into mechanisms of substrate recognition by unusual pentameric E3 ligases and highlight the KCTD family as emerging regulators of GPCR signaling.